Life Sciences Commercialisation in Finland: Overview

Thomson Reuters Practical Law Life Sciences Global Guide 2023

More by the same author

Reform of the Act on the Secondary Use of Social and Health Data

The Act on the Secondary Use of Social and Health Data (552/2019) is being reformed The Act on the Secondary Use of Social and Health Data (552/2019) (the “Secondary Use Act”), which lays out rules on the use of social and health data in Finland for secondary purposes, entered into force in May 2019. Secondary use of social and health data refers to the use of such data for statistics, scientific research, development and innovation, education, policy-making and regulatory activities by public authorities.

New Legislation on Environmental Marketing: Sustainable Businesses Benefit from Ban on Greenwashing

New EU legislation on green claims will bring opportunities to sustainable businesses, although ensuring compliance with the new rules will require preparatory efforts from companies. As stricter and more detailed rules will apply to environmental claims and marketing, to prevent so-called greenwashing, companies with a genuinely sustainable product range will benefit from the new framework. Prohibition of greenwashing brings advantages to both consumers and businesses – and naturally to the environment.

The EU’s Pharmaceutical Legislation Reform

The European Union’s imminent pharmaceutical legislation reform aims to modernise its regulatory framework, focusing on improving patient access to medicines, fostering innovation, and minimising environmental impact. This strategic overhaul, set against a backdrop of industry challenges and evolving IP rights, underscores the EU’s commitment to balancing innovation with accessibility and sustainability in healthcare.

Latest insights

Liability for sanctions violations is increasing in Finland

Article / 20 May 2025

Proposed Amendments to Finnish Electricity Market Act Published

Article / 12 May 2025